Document is current

Any future updates will be listed below

Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan

Crossref DOI link: https://doi.org/10.1007/s12185-018-02564-z

Published Online: 2018-12-17

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark